Prednisolone Sodium Phosphate Oral Solution Equivalent to prednisolone 25 mg/5 mL is indicated for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with asthma or asthma caused by respiratory disorders.
Please see full Prescribing Information for a complete list of indications.
It should be emphasized that dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/Safety/MedWatch, or call 1-800-FDA-1088.
For a summary of all risks associated with this product, please click here for full Prescribing Information.
No front page content has been created yet.